[go: up one dir, main page]

GB0921805D0 - Drug composition and its use in therapy - Google Patents

Drug composition and its use in therapy

Info

Publication number
GB0921805D0
GB0921805D0 GBGB0921805.8A GB0921805A GB0921805D0 GB 0921805 D0 GB0921805 D0 GB 0921805D0 GB 0921805 A GB0921805 A GB 0921805A GB 0921805 D0 GB0921805 D0 GB 0921805D0
Authority
GB
United Kingdom
Prior art keywords
therapy
drug composition
drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0921805.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocopea Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB0921805.8A priority Critical patent/GB0921805D0/en
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of GB0921805D0 publication Critical patent/GB0921805D0/en
Priority to CN2010800570306A priority patent/CN102740843A/en
Priority to PE2012000813A priority patent/PE20121537A1/en
Priority to RU2012129839/15A priority patent/RU2564904C2/en
Priority to CN201610214436.XA priority patent/CN105816462A/en
Priority to SG2012043642A priority patent/SG181686A1/en
Priority to EP10795446A priority patent/EP2512464A1/en
Priority to UAA201208706A priority patent/UA105944C2/en
Priority to JP2012543902A priority patent/JP2013513651A/en
Priority to PH1/2012/501203A priority patent/PH12012501203A1/en
Priority to MX2012006625A priority patent/MX343222B/en
Priority to NZ600243A priority patent/NZ600243A/en
Priority to SG10201408377QA priority patent/SG10201408377QA/en
Priority to PCT/GB2010/052085 priority patent/WO2011073646A1/en
Priority to AU2010332494A priority patent/AU2010332494B2/en
Priority to BR112012014161A priority patent/BR112012014161A2/en
Priority to CA2784214A priority patent/CA2784214C/en
Priority to US13/446,217 priority patent/US20120252824A1/en
Priority to ZA2012/04293A priority patent/ZA201204293B/en
Priority to CO12098537A priority patent/CO6541630A2/en
Priority to ECSP12012132 priority patent/ECSP12012132A/en
Priority to IL220383A priority patent/IL220383A/en
Priority to US14/287,017 priority patent/US10016437B2/en
Priority to US14/287,014 priority patent/US9314465B2/en
Priority to US14/287,015 priority patent/US9308211B2/en
Priority to US14/488,215 priority patent/US20150005325A1/en
Priority to US14/687,393 priority patent/US20150216869A1/en
Priority to JP2015189231A priority patent/JP2016040279A/en
Priority to US14/991,892 priority patent/US20160120899A1/en
Priority to US15/061,656 priority patent/US9700561B2/en
Priority to US15/063,465 priority patent/US9675618B2/en
Priority to US15/144,798 priority patent/US20160271136A1/en
Priority to US15/144,800 priority patent/US20160271197A1/en
Priority to US16/042,670 priority patent/US10420812B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0921805.8A 2009-06-16 2009-12-14 Drug composition and its use in therapy Ceased GB0921805D0 (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
GBGB0921805.8A GB0921805D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
CA2784214A CA2784214C (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough
EP10795446A EP2512464A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough
JP2012543902A JP2013513651A (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use to treat cough
RU2012129839/15A RU2564904C2 (en) 2009-12-14 2010-12-14 Theobromine-decongestant combination and application thereof for treating cough
CN201610214436.XA CN105816462A (en) 2009-12-14 2010-12-14 Drug combination with theobromine and its use in therapy
SG2012043642A SG181686A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough
CN2010800570306A CN102740843A (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough
UAA201208706A UA105944C2 (en) 2009-12-14 2010-12-14 Drug formulation with theobromine and decongestant for treatment of cough
PE2012000813A PE20121537A1 (en) 2009-12-14 2010-12-14 COMBINATION OF THEOBROMINE WITH A DECONGESTIVE
PH1/2012/501203A PH12012501203A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough
MX2012006625A MX343222B (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough.
NZ600243A NZ600243A (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough
SG10201408377QA SG10201408377QA (en) 2009-12-14 2010-12-14 Combination Of Theobromine With A Decongestant And Its Use For The Treatment Of Cough
PCT/GB2010/052085 WO2011073646A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough
AU2010332494A AU2010332494B2 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough
BR112012014161A BR112012014161A2 (en) 2009-12-14 2010-12-14 theobromine-based pharmaceutical composition and a decongestant and its use in the treatment of cough
US13/446,217 US20120252824A1 (en) 2009-06-16 2012-04-13 Drug Combinations and Uses in Treating a Coughing Condition
ZA2012/04293A ZA201204293B (en) 2009-12-14 2012-06-12 Combination of theobromine with a decongestant and its use for the treatment of cough
ECSP12012132 ECSP12012132A (en) 2009-12-14 2012-06-12 COMBINATION OF THEOBROMINE WITH A DESCONGESTIVE AND ITS USE FOR THE TOS TREATMENT
CO12098537A CO6541630A2 (en) 2009-12-14 2012-06-12 THEOBROMINE COMBINATION WITH A DESCONGESTIVO AND ITS USE FOR THE TOS TREATMENT
IL220383A IL220383A (en) 2009-12-14 2012-06-13 Combination of theobromine with a decongestant for the treatment of cough
US14/287,017 US10016437B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/287,014 US9314465B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/287,015 US9308211B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/488,215 US20150005325A1 (en) 2009-06-16 2014-09-16 Drug Combinations and Uses in Treating a Coughing Condition
US14/687,393 US20150216869A1 (en) 2009-06-16 2015-04-15 Drug Combinations and Uses in Treating a Coughing Condition
JP2015189231A JP2016040279A (en) 2009-12-14 2015-09-28 Combination of theobromine with a decongestant and its use to treat cough
US14/991,892 US20160120899A1 (en) 2009-06-16 2016-01-08 Drug Combinations and Uses in Treating a Coughing Condition
US15/061,656 US9700561B2 (en) 2009-06-16 2016-03-04 Drug combinations and uses in treating a coughing condition
US15/063,465 US9675618B2 (en) 2009-06-16 2016-03-07 Drug combinations and uses in treating a coughing condition
US15/144,798 US20160271136A1 (en) 2009-06-16 2016-05-02 Drug Combinations and Uses in Treating a Coughing Condition
US15/144,800 US20160271197A1 (en) 2009-06-16 2016-05-02 Drug Combinations and Uses in Treating a Coughing Condition
US16/042,670 US10420812B2 (en) 2009-06-16 2018-07-23 Drug combinations and uses in treating a coughing condition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921805.8A GB0921805D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
GB0921805D0 true GB0921805D0 (en) 2010-01-27

Family

ID=41667045

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0921805.8A Ceased GB0921805D0 (en) 2009-06-16 2009-12-14 Drug composition and its use in therapy

Country Status (19)

Country Link
EP (1) EP2512464A1 (en)
JP (2) JP2013513651A (en)
CN (2) CN102740843A (en)
AU (1) AU2010332494B2 (en)
BR (1) BR112012014161A2 (en)
CA (1) CA2784214C (en)
CO (1) CO6541630A2 (en)
EC (1) ECSP12012132A (en)
GB (1) GB0921805D0 (en)
IL (1) IL220383A (en)
MX (1) MX343222B (en)
NZ (1) NZ600243A (en)
PE (1) PE20121537A1 (en)
PH (1) PH12012501203A1 (en)
RU (1) RU2564904C2 (en)
SG (2) SG181686A1 (en)
UA (1) UA105944C2 (en)
WO (1) WO2011073646A1 (en)
ZA (1) ZA201204293B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (en) 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6417206B1 (en) * 2001-01-26 2002-07-09 Medpointe Healthcare Inc. Antitussive/antihist aminic/decongestant compositions
JP2002308761A (en) * 2001-04-09 2002-10-23 Taisho Pharmaceut Co Ltd Cold cough medicine
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
JP4377564B2 (en) * 2002-05-02 2009-12-02 ロート製薬株式会社 Composition for internal use
RU2311919C2 (en) * 2002-12-30 2007-12-10 Каунсел Оф Сайнтифик Энд Индастриал Рисерч Development of anti-coughing and throat softening herbal composition
US20040202677A1 (en) * 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (en) * 2006-07-25 2008-01-30 안국약품 주식회사 Cough Treatment Composition
CN100518775C (en) * 2007-03-16 2009-07-29 邓丽菊 Medicine composition for treating cough and asthma and preparation thereof

Also Published As

Publication number Publication date
CN105816462A (en) 2016-08-03
IL220383A (en) 2017-01-31
ZA201204293B (en) 2013-02-27
UA105944C2 (en) 2014-07-10
NZ600243A (en) 2013-07-26
PE20121537A1 (en) 2012-12-21
CA2784214C (en) 2018-01-09
AU2010332494B2 (en) 2015-01-15
CA2784214A1 (en) 2011-06-23
WO2011073646A1 (en) 2011-06-23
BR112012014161A2 (en) 2016-05-17
SG10201408377QA (en) 2015-02-27
JP2016040279A (en) 2016-03-24
RU2012129839A (en) 2014-01-27
SG181686A1 (en) 2012-07-30
MX343222B (en) 2016-10-28
PH12012501203A1 (en) 2012-11-05
EP2512464A1 (en) 2012-10-24
RU2564904C2 (en) 2015-10-10
CO6541630A2 (en) 2012-10-16
MX2012006625A (en) 2012-10-05
CN102740843A (en) 2012-10-17
IL220383A0 (en) 2012-08-30
JP2013513651A (en) 2013-04-22
ECSP12012132A (en) 2012-09-28
AU2010332494A1 (en) 2012-06-14

Similar Documents

Publication Publication Date Title
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
IL218169A (en) Quinazoline compounds and pharmaceutical compositions comprising same for use in therapy
GB0817207D0 (en) therapeutic apsac compounds and their use
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
IL214244A0 (en) Scriptaid isosteres and their use in therapy
GB0921803D0 (en) Drug composition and its use in therapy
HK1168283A1 (en) Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto sorcs1
IL219768A0 (en) Drug combination with thebromine and its use in therapy
GB2460178B (en) Depsipeptides and their therapeutic use
IL219769A0 (en) Drug combination with theromine and its use in therapy
GB2460181B (en) Depsipeptides and their therapeutic use
GB0921805D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
GB0905970D0 (en) Depsipeptides and their therapeutic use
GB2460180B (en) Depsipeptides and their therapeutic use
GB0909354D0 (en) Drug composition and its use in therapy
GB0918727D0 (en) Drug composition and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy
GB0909344D0 (en) Drug composition and its uses in therapy
GB0920267D0 (en) Drug combination and its use in therapy
GB201019971D0 (en) Drug composition and its use in therapy
GB201019972D0 (en) Drug composition and its use in therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)